Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Prepaid Assets (2019 - 2025)

Historic Prepaid Assets for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to $9.3 million.

  • Silence Therapeutics' Prepaid Assets fell 4042.54% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 4042.54%. This contributed to the annual value of $14.7 million for FY2024, which is 2608.77% up from last year.
  • Latest data reveals that Silence Therapeutics reported Prepaid Assets of $9.3 million as of Q3 2025, which was down 4042.54% from $14.4 million recorded in Q2 2025.
  • Silence Therapeutics' 5-year Prepaid Assets high stood at $16.4 million for Q1 2025, and its period low was $4.0 million during Q3 2021.
  • Its 5-year average for Prepaid Assets is $11.0 million, with a median of $10.9 million in 2022.
  • In the last 5 years, Silence Therapeutics' Prepaid Assets surged by 20680.82% in 2022 and then tumbled by 4042.54% in 2025.
  • Over the past 5 years, Silence Therapeutics' Prepaid Assets (Quarter) stood at $5.8 million in 2021, then surged by 65.58% to $9.6 million in 2022, then increased by 17.88% to $11.3 million in 2023, then increased by 29.34% to $14.7 million in 2024, then tumbled by 36.85% to $9.3 million in 2025.
  • Its Prepaid Assets was $9.3 million in Q3 2025, compared to $14.4 million in Q2 2025 and $16.4 million in Q1 2025.